The association of smoking with venous thrombosis in women: A population-based, case-control study

Thrombosis and Haemostasis

Volumn 109, Issue 5, 2013, Pages 891-896

  Blondon, Marc ^a,d   Wiggins, Kerri L ^a   Mcknight, Barbara ^a   Psaty, Bruce M ^a,b   Rice, Kenneth M ^a   Heckbert, Susan R ^a,b   Smith, Nicholas L ^a,b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Epidemiology; Smoking; Thromboembolism; Venous thrombosis; Women

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK; SMOKING; TELECONSULTATION; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; LINEAR MODELS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PULMONARY EMBOLISM; RISK ASSESSMENT; RISK FACTORS; SEDENTARY LIFESTYLE; SEX FACTORS; SMOKING; VENOUS THROMBOSIS; WASHINGTON; YOUNG ADULT;

EID: 84877037259     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-10-0732     Document Type: Article

References (29)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-- 2011 update: a report from the American Heart Association. Circulation 2011; 123: e18-e209.
2. Centers for Disease Control and Prevention (CDC). Current cigarette smoking prevalence among working adults--United States, 2004-2010. Morb Mortal Wkly Rep 2011; 60: 1305-1309.
3. Ageno W, Becattini C, Brighton T, et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008; 117: 93-102.
4. Pomp ER, Rosendaal FR, Doggen CJM. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol 2008; 83: 97-102.
5. Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation 2010; 121: 1896-1903.
6. Severinsen MT, Kristensen SR, Johnsen SP, et al. Smoking and venous thromboembolism: a Danish follow-up study. J Thromb Haemost 2009; 7: 1297-1303.
7. Wattanakit K, Lutsey PL, Bell EJ, et al. Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb Haemost 2012; 108: 508-515.
8. Lutsey PL, Virnig BA, Durham SB, et al. Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health 2010; 100: 1506-1513.
9. Enga KF, Braekkan SK, Hansen-Krone IJ, et al. Cigarette smoking and the risk of venous thromboembolism. the tromsø study. J Thromb Haemost 2012; 10: 2068-2074.
10. Smith NL, Heckbert SR, Lemaitre RN, et al. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. J Am Med Assoc 2004; 292: 1581-1587.
11. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. J Am Med Assoc 1995; 274: 620-625.
12. Psaty BM, Heckbert SR, Atkins D, et al. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med 1994; 154: 1333-1339.
13. Heckbert SR, Wiggins KL, Glazer NL, et al. Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population. Am J Hypertens 2009; 22: 538-544.
14. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res 1999; 8: 3-15.
15. Stata. Base Reference Manual (3 volumes). Stat Press; 2009.
16. Koepsell T, Weiss N. Epidemiologic Methods: Studying the Occurrence of Illness. First edition. Oxford University Press; 2003.
17. Roos NP, Carrière KC, Friesen D. Factors influencing the frequency of visits by hypertensive patients to primary care physicians in Winnipeg. CMAJ 1998; 159: 777-83.
18. Starfield B, Weiner J, Mumford L, et al. Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res 1991; 26: 53-74.
19. Lee KW, Lip GYH. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 2003; 163: 2368-2392.
20. Bazzano LA, He J, Muntner, et al. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 2003; 138: 891-897.
21. Barua RS, Sy F, Srikanth S, et al. Acute cigarette smoke exposure reduces clot lysis--association between altered fibrin architecture and the response to t-PA. Thromb Res 2010; 126: 426-430.
22. Barua RS, Sy F, Srikanth S, et al. Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation. Arterioscler Thromb Vasc Biol 2010; 30: 75-79.
23. Bakhru A, Erlinger TP. Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med 2005; 2: e160.
24. Caponnetto P, Russo C, Di Maria A, et al. Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study. Eur J Clin Invest 2011; 41: 616-626.
25. Rigotti NA, Pipe AL, Benowitz NL, et al. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation 2010; 121: 221-229.
26. Prochaska JJ, Hilton JF. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. Br Med J 2012; 344: e2856.
27. Caraballo RS, Giovino GA, Pechacek TF, et al. Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2001; 153: 807-814.
28. Rosengren A, Fredén M, Hansson P-O, et al. Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost 2008; 6: 558-564.
29. Becattini C, Agnelli G, Schenone A, et al. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 2012; 366: 1959-1967.